Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis.
暂无分享,去创建一个
Hanlee P. Ji | M. King | K. Heimdal | P. Møller | Ming K. Lee | H. Lubs | B. Gjertsen | P. Macleod | B. Gjertsen | M. Lee | J. Dann | J. F. Arena | K. Swisshelm | E. Lynch | H. Ji | S. Kvinnsland | E. A. Ostermeyer | D. Suchard | P. MacLeod
[1] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[2] P. Guldberg,et al. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. , 1997, Cancer research.
[3] J. Boyd,et al. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. , 1997, Cancer research.
[4] M. Nelen,et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.
[5] C. Eng,et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome , 1997, Nature Genetics.
[6] Hong Sun,et al. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. , 1997, Cancer research.
[7] Jing Li,et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.
[8] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[9] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[10] L. Maquat. Defects in RNA splicing and the consequence of shortened translational reading frames. , 1996, American journal of human genetics.
[11] S. Peltz,et al. Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. , 1995, Genes & development.
[12] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[13] E. Neufeld,et al. Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles. , 1994, Cellular and molecular biology.
[14] R Parker,et al. Mechanisms of mRNA degradation in eukaryotes. , 1994, Trends in biochemical sciences.
[15] S. Malcolm,et al. Proteolipid protein gene dosage effect in Pelizaeus–Merzbacher disease , 1994, Nature Genetics.
[16] Yusuke Nakamura,et al. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: Frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p , 1994, Genes, chromosomes & cancer.
[17] R. Pulak,et al. mRNA surveillance by the Caenorhabditis elegans smg genes. , 1993, Genes & development.
[18] R. Spetzler,et al. Cowden syndrome and lhermitte‐duclos disease , 1992, Cancer.
[19] L. Maquat,et al. Nonsense codons in human beta-globin mRNA result in the production of mRNA degradation products , 1992, Molecular and cellular biology.
[20] S. Peltz,et al. The product of the yeast UPF1 gene is required for rapid turnover of mRNAs containing a premature translational termination codon. , 1991, Genes & development.
[21] B. Gallie,et al. Mutations in the RB1 gene and their effects on transcription , 1989, Molecular and cellular biology.
[22] P. Fialkow,et al. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. , 1984, Blood.
[23] W. Henle,et al. Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma. , 1970, Bibliotheca haematologica.